Orion Corporation recently converted 62,752 A shares into B shares, bringing the total number of shares to 141,134,278. This includes 31,524,740 A shares and 109,609,538 B shares, with a total of 740,104,338 votes. Orion is a pharmaceutical company with a focus on oncology and pain, generating EUR 1,542 million in net sales in 2024. Employing around 3,700 professionals globally, Orion is committed to building well-being through its portfolio of proprietary and generic medicines. Its A and B shares are listed on Nasdaq Helsinki.

Read more at GlobeNewswire: 62,752 Orion Corporation A shares converted into B shares